Simple. Most larger companies spend money on R&D.
LSH clearly stated in their quarterly for October to December that they had received $150k in sales for implementation works done in the first week of January. So we can safely say they finished those works in the quarter and payment just happened to be received after December 31.
LSH spent a further $600k on R&D in the January to March quarter and received an additional $16k in revenue (on top of the $150k previously stated). It makes sense for B Braun and Beurer to have LSH develop the bodytel system as part of their R&D.
Australian investors are effectively subsidising $580k+ towards their research. It's a win win for the companies.
Once LSH have exhausted all their cash reserves, either B Braun or Beurer will have the opportunity to buy out the company for effectively nothing.
Can anyone actually show me an ASX announcement specifically stating B Braun will use the Bodytel software in their Omnitest BT?
Simple. Most larger companies spend money on R&D. LSH clearly...
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.073M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14046 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 29629 | 1 |
View Market Depth
| Last trade - 10.04am 30/04/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable